OTCMKTS:MICR

Micron Solutions Competitors

$3.00
-0.09 (-2.91 %)
(As of 04/9/2021 10:07 PM ET)
Add
Compare
Today's Range
$3.00
Now: $3.00
$3.50
50-Day Range
$2.97
MA: $3.21
$3.47
52-Week Range
$1.05
Now: $3.00
$3.90
Volume5,900 shs
Average Volume5,292 shs
Market Capitalization$10.09 million
P/E Ratio21.43
Dividend YieldN/A
Beta0.5

Competitors

Micron Solutions (OTCMKTS:MICR) Vs. FCRE, VIVE, CHFS, RSLS, PEYE, and VASO

Should you be buying MICR stock or one of its competitors? Companies in the industry of "electromedical equipment" are considered alternatives and competitors to Micron Solutions, including Fc Global Realty (FCRE), Viveve Medical (VIVE), CHF Solutions (CHFS), ReShape Lifesciences (RSLS), Precision Optics (PEYE), and Vaso (VASO).

Micron Solutions (OTCMKTS:MICR) and Fc Global Realty (OTCMKTS:FCRE) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Micron Solutions and Fc Global Realty, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Micron Solutions0000N/A
Fc Global Realty0000N/A

Risk and Volatility

Micron Solutions has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Fc Global Realty has a beta of 2.31, suggesting that its stock price is 131% more volatile than the S&P 500.

Profitability

This table compares Micron Solutions and Fc Global Realty's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Micron Solutions2.26%19.35%4.88%
Fc Global Realty-4,265.28%-24.94%-9.42%

Valuation and Earnings

This table compares Micron Solutions and Fc Global Realty's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Micron Solutions$17.50 million0.58$-2,140,000.00N/AN/A
Fc Global Realty$40,000.00971.79$-2,040,000.00N/AN/A

Fc Global Realty has lower revenue, but higher earnings than Micron Solutions.

Summary

Micron Solutions beats Fc Global Realty on 4 of the 7 factors compared between the two stocks.

Micron Solutions (OTCMKTS:MICR) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings.

Valuation & Earnings

This table compares Micron Solutions and Viveve Medical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Micron Solutions$17.50 million0.58$-2,140,000.00N/AN/A
Viveve Medical$6.57 million5.12$-42,530,000.00($338.00)-0.01

Micron Solutions has higher revenue and earnings than Viveve Medical.

Profitability

This table compares Micron Solutions and Viveve Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Micron Solutions2.26%19.35%4.88%
Viveve Medical-661.57%-243.62%-139.23%

Institutional and Insider Ownership

18.2% of Viveve Medical shares are held by institutional investors. 26.1% of Micron Solutions shares are held by company insiders. Comparatively, 5.0% of Viveve Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

Micron Solutions has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Micron Solutions and Viveve Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Micron Solutions0000N/A
Viveve Medical00103.00

Summary

Micron Solutions beats Viveve Medical on 7 of the 11 factors compared between the two stocks.

Micron Solutions (OTCMKTS:MICR) and CHF Solutions (NASDAQ:CHFS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings.

Valuation & Earnings

This table compares Micron Solutions and CHF Solutions' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Micron Solutions$17.50 million0.58$-2,140,000.00N/AN/A
CHF Solutions$5.51 million5.92$-18,110,000.00($279.28)-0.02

Micron Solutions has higher revenue and earnings than CHF Solutions.

Profitability

This table compares Micron Solutions and CHF Solutions' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Micron Solutions2.26%19.35%4.88%
CHF Solutions-254.26%-173.61%-131.01%

Institutional and Insider Ownership

65.1% of CHF Solutions shares are held by institutional investors. 26.1% of Micron Solutions shares are held by company insiders. Comparatively, 0.6% of CHF Solutions shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

Micron Solutions has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, CHF Solutions has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Micron Solutions and CHF Solutions, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Micron Solutions0000N/A
CHF Solutions00103.00

CHF Solutions has a consensus target price of $20.00, indicating a potential upside of 270.37%. Given CHF Solutions' higher possible upside, analysts clearly believe CHF Solutions is more favorable than Micron Solutions.

Summary

Micron Solutions beats CHF Solutions on 7 of the 12 factors compared between the two stocks.

Micron Solutions (OTCMKTS:MICR) and ReShape Lifesciences (OTCMKTS:RSLS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings.

Valuation & Earnings

This table compares Micron Solutions and ReShape Lifesciences' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Micron Solutions$17.50 million0.58$-2,140,000.00N/AN/A
ReShape Lifesciences$15.09 million1.70$-74,210,000.00N/AN/A

Micron Solutions has higher revenue and earnings than ReShape Lifesciences.

Profitability

This table compares Micron Solutions and ReShape Lifesciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Micron Solutions2.26%19.35%4.88%
ReShape Lifesciences-314.18%-186.31%-101.10%

Volatility and Risk

Micron Solutions has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, ReShape Lifesciences has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Micron Solutions and ReShape Lifesciences, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Micron Solutions0000N/A
ReShape Lifesciences00103.00

Summary

Micron Solutions beats ReShape Lifesciences on 5 of the 8 factors compared between the two stocks.

Micron Solutions (OTCMKTS:MICR) and Precision Optics (OTCMKTS:PEYE) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings.

Valuation & Earnings

This table compares Micron Solutions and Precision Optics' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Micron Solutions$17.50 million0.58$-2,140,000.00N/AN/A
Precision Optics$9.92 million2.25$-1,430,000.00N/AN/A

Precision Optics has lower revenue, but higher earnings than Micron Solutions.

Analyst Ratings

This is a breakdown of current recommendations for Micron Solutions and Precision Optics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Micron Solutions0000N/A
Precision Optics0000N/A

Volatility and Risk

Micron Solutions has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500.

Profitability

This table compares Micron Solutions and Precision Optics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Micron Solutions2.26%19.35%4.88%
Precision Optics-13.17%-46.31%-22.21%

Summary

Micron Solutions beats Precision Optics on 5 of the 8 factors compared between the two stocks.

Vaso (OTCMKTS:VASO) and Micron Solutions (OTCMKTS:MICR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, dividends, profitability and analyst recommendations.

Valuation and Earnings

This table compares Vaso and Micron Solutions' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vaso$75.75 million0.28$40,000.00N/AN/A
Micron Solutions$17.50 million0.58$-2,140,000.00N/AN/A

Vaso has higher revenue and earnings than Micron Solutions.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Vaso and Micron Solutions, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Vaso0000N/A
Micron Solutions0000N/A

Risk & Volatility

Vaso has a beta of 3.26, suggesting that its stock price is 226% more volatile than the S&P 500. Comparatively, Micron Solutions has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500.

Profitability

This table compares Vaso and Micron Solutions' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Vaso3.01%46.49%4.60%
Micron Solutions2.26%19.35%4.88%

Summary

Vaso beats Micron Solutions on 5 of the 8 factors compared between the two stocks.


Micron Solutions Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Fc Global Realty logo
FCRE
Fc Global Realty
0.5$0.10-90.1%$38.87 million$40,000.000.00Gap Up
Viveve Medical logo
VIVE
Viveve Medical
0.9$3.25-5.2%$33.61 million$6.57 million-0.01
CHF Solutions logo
CHFS
CHF Solutions
1.7$5.40-1.9%$32.60 million$5.51 million-0.11
ReShape Lifesciences logo
RSLS
ReShape Lifesciences
0.6$4.15-0.7%$25.59 million$15.09 million0.00
PEYE
Precision Optics
0.4$1.69-5.0%$22.35 million$9.92 million-16.85Gap Down
Vaso logo
VASO
Vaso
0.9$0.12-5.7%$21.30 million$75.75 million5.75News Coverage
STRR
Star Equity
0.1$3.30-2.7%$16.24 million$114.18 million-1.05
GTHP
Guided Therapeutics
0.3$0.75-4.6%$10.41 million$40,000.00-3.13Gap Up
NIMU
Non-Invasive Monitoring Systems
0.5$0.03-11.8%$2.69 millionN/A0.00Gap Up
RSLSD
ReShape Lifesciences
0.4$5.37-2.2%$1.94 million$610,000.000.00High Trading Volume
MAGAA
Magna-Lab
0.7$1.17-41.0%$1.20 millionN/A6.50Gap Up
Nexeon MedSystems logo
NXNN
Nexeon MedSystems
0.7$0.55-29.1%$1.12 millionN/A0.00Gap Down
ARDMQ
Aradigm
0.0$0.05-8.7%$764,000.00N/A0.00Gap Up
Echo Therapeutics logo
ECTE
Echo Therapeutics
0.5$0.03-1.9%$359,000.00N/A0.00
IMRIS logo
IMRSQ
IMRIS
0.5$0.01-0.0%$312,000.00N/A0.00
SCIE
SpectraScience
0.5$0.00-0.0%$265,000.00N/A0.00
ULGX
Urologix
0.6$0.01-43.3%$192,000.00N/A0.00Gap Down
AKSY
Aksys
0.0$0.00-40.0%$0.00N/A0.00Gap Down
Escalon Medical logo
ESMC
Escalon Medical
0.5$0.35-5.7%$0.00$9.40 million-5.83Gap Down
HRTT
Heart Tronics
0.0$0.15-466.7%$0.00N/A0.00Gap Up
IVVI
Ivivi Technologies
0.0$0.00-0.0%$0.00N/A0.00High Trading Volume
NWCI
NewCardio
0.5$0.00-14.7%$0.00N/A0.00Gap Up
PECN
Photoelectron
0.2$0.03-3.8%$0.00N/A0.00Gap Up
Trimedyne logo
TMED
Trimedyne
0.4$4.25-0.2%$0.00$5.57 million0.00
XCRP
Xcorporeal
0.0$0.00-0.0%$0.00N/A0.00
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.